0 references
Omecamtiv mecarbil does not prolong QTc intervals at therapeutic concentrations
British Journal of Clinical Pharmacology2021Vol. 88(1), pp. 187–198
Ashit Trivedi, Cheng‐Pang Hsu, Pegah Jafarinasabian, Bianca Terminello, Hanze Zhang, Stephen Flach, Samuel Israel, Ashley Brooks, Hongqi Xue, Börje Darpö, Siddique Abbasi, Sandeep Dutta, Edward Lee
Abstract
OM does not have a clinically relevant effect on the studied ECG parameters.
Related Papers
- → Highly Automated QT Measurement Techniques in 7 Thorough QT Studies Implemented under ICH E14 Guidelines(2011)36 cited
- → Detecting moxifloxacin‐induced QTc prolongation in thorough QT and early clinical phase studies using a highly automated ECG analysis approach(2016)22 cited
- → Pharmacokinetic–pharmacodynamic modelling of the effect of Moxifloxacin on QTc prolongation in telemetered cynomolgus monkeys(2011)34 cited
- → Severe QT interval prolongation associated with moxifloxacin: a case report(2008)11 cited
- → Sensitivity of common marmosets to detect drug-induced QT interval prolongation: Moxifloxacin case study(2010)12 cited